tirzepatide taken off shortage list Compounders lose battle over Eli Lilly weight loss drug and FDA Lilly CEO says weight-loss drug

When a needle goes through the skin and into the fatty tissue below, it can sometimes hit or tear a capillary

The execution around logistics and platform usability has room for improvement

This suggests the eventual prescribing approach may involve reaching a target weight and then adjusting the dose downward to maintain it, rather than stopping treatment entirely

From a pharmacovigilance perspective, phentermine shows fewer serious adverse events than several newer agents when prescribed as monotherapy

Rescue Therapy and Safety Findings Rescue therapy with 1 mg orforglipron was initiated for placebo subjects who regained 50% of the weight loss achieved in SURMOUNT-5

10.3748/wjg.v22.i22.5211 522 ZhuG.ZhaoJ.WangG.ChenW